APA

Mehlhorn G., Hautmann S. K., Koch M. C., Strehl J. D., Hartmann A., Hilfrich R., Beckmann M. W. & Griesser H. (20141111). HPV16-L1-specific antibody response is associated with clinical remission of high-risk HPV-positive early dysplastic lesions. : Anticancer research.

Chicago

Mehlhorn Grit, Hautmann Simone K, Koch Martin C, Strehl Johanna D, Hartmann Arndt, Hilfrich Ralf, Beckmann Matthias W and Griesser Henrik. 20141111. HPV16-L1-specific antibody response is associated with clinical remission of high-risk HPV-positive early dysplastic lesions. : Anticancer research.

Harvard

Mehlhorn G., Hautmann S. K., Koch M. C., Strehl J. D., Hartmann A., Hilfrich R., Beckmann M. W. and Griesser H. (20141111). HPV16-L1-specific antibody response is associated with clinical remission of high-risk HPV-positive early dysplastic lesions. : Anticancer research.

MLA

Mehlhorn Grit, Hautmann Simone K, Koch Martin C, Strehl Johanna D, Hartmann Arndt, Hilfrich Ralf, Beckmann Matthias W and Griesser Henrik. HPV16-L1-specific antibody response is associated with clinical remission of high-risk HPV-positive early dysplastic lesions. : Anticancer research. 20141111.